The FDA has approved these medications for use in patients with type 2 diabetes and for weight loss in individuals meeting certain criteria, such as BMI and weight-related conditions
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A (2022) SURMOUNT-1 Investigators
Download the full COA report for this product
And honestly, the costs can feel opaque, sprawling, and sometimes downright intimidating
A: Cagrilintide is an amylin analogue
Heres what you need to know about the carnivore diet